Drug Shortage Report for TEVA-BUDESONIDE
| Report ID | 234891 |
| Drug Identification Number | 02465949 |
| Brand name | TEVA-BUDESONIDE |
| Common or Proper name | BUDESONIDE INH 0.125MG/ML 2ML |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | BUDESONIDE |
| Strength(s) | 0.125MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INHALATION INHALATION |
| Packaging size | 20pk |
| ATC code | R03BA |
| ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-08-08 |
| Estimated end date | 2025-10-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-03-13 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v23 | 2025-03-13 | French | Compare |
| v22 | 2025-03-13 | English | Compare |
| v21 | 2025-02-13 | French | Compare |
| v20 | 2025-02-13 | English | Compare |
| v19 | 2025-02-06 | French | Compare |
| v18 | 2025-02-06 | English | Compare |
| v17 | 2025-01-23 | French | Compare |
| v16 | 2025-01-23 | English | Compare |
| v15 | 2025-01-15 | French | Compare |
| v14 | 2025-01-15 | English | Compare |
| v13 | 2024-12-19 | French | Compare |
| v12 | 2024-12-19 | English | Compare |
| v11 | 2024-11-21 | French | Compare |
| v10 | 2024-11-21 | English | Compare |
| v9 | 2024-11-08 | French | Compare |
| v8 | 2024-11-08 | English | Compare |
| v7 | 2024-11-01 | French | Compare |
| v6 | 2024-11-01 | English | Compare |
| v5 | 2024-10-11 | French | Compare |
| v4 | 2024-10-11 | English | Compare |